April 18, 2024 — New evidence-based research calls into question the conventional three-month blanking period immediately after atrial fibrillation (AF) ablation, when early occurrences of AF are ...
Diagnostic and Interventional Cardiology DAIC
Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.
Did you know that you have instant access to the latest webinars from Diagnostic and Interventional Cardiology?
DAIC ...
April 25, 2024 —Heart-Valve-Surgery.com, a leading patient advocacy group for heart valve disease, with support from Med ...
April 25, 2024 — Atlantic Health System’s Morristown Medical Center treated the first patient in New Jersey using Edward ...
April 23, 2024 — A recent study designed and implemented by investigators at Cedars-Sinai found that artificial ...
April 23, 2024 — Medtronic plc, a global leader in healthcare technology, today announced the launch of its latest ...
April 22, 2024 — At the annual American College of Cardiology conference (ACC.24) in Atlanta last week, RCE Technologies ...
April 22, 2024 — Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, welcomes the ...
April 18, 2024 — New evidence-based research calls into question the conventional three-month blanking period ...
April 18, 2024 — Bayer AG and Asklepios BioPharmaceutical, Inc., a gene therapy company wholly owned and independently ...
April 17, 2024 — Getinge and Cook Medical announced an exclusive sales and distribution agreement for the iCast covered ...
April 17, 2024 —CPR Therapeutics, Inc. (CPR-T), an early-stage medtech startup funded by the N.I.H and N.S.F to develop ...
April 16, 2024 — Each year more than 500,000 Americans undergo percutaneous coronary intervention, or PCI, a minimally ...
April 16, 2024 — Vivasure Medical, a company pioneering novel fully absorbable technology for percutaneous vessel ...
April 16, 2024 — CVRx, Inc., a commercial-stage medical device company, announced today the availability of additional ...
April 15, 2024 — The U.S. Food and Drug Administration (FDA) announced Abbott/Thoratec Corp. is recalling HeartMate II ...